Congestive heart failure pathophysiology: Difference between revisions

Jump to navigation Jump to search
Line 20: Line 20:
* In heart failure, there is a failure of blood to move forward (forward failure) and a tendency of blood to move back ward (backward failure).
* In heart failure, there is a failure of blood to move forward (forward failure) and a tendency of blood to move back ward (backward failure).
* Normally, with respect to the left side of the heart, blood flows from the lungs, into the [[pulmonary veins]], into the [[left atrium]], through the [[mitral valve]], and finally into the [[left ventricle]]. When the [[left ventricle]] cannot be normally filled during diastole, blood will back up into the [[left atrium]] and, eventually, into the lungs. The result is a higher than normal pressure of blood within the vessels of the lung. As a result of hydrostatic forces, this high pressure leads to leaking of fluid (i.e. [[transudate]]) from the lung's blood vessels into the air-spaces ([[alveoli]]) of the lungs. The result is [[pulmonary edema]], a condition characterized by difficulty breathing, inadequate [[oxygenation]] of blood, and, if severe and untreated, death.
* Normally, with respect to the left side of the heart, blood flows from the lungs, into the [[pulmonary veins]], into the [[left atrium]], through the [[mitral valve]], and finally into the [[left ventricle]]. When the [[left ventricle]] cannot be normally filled during diastole, blood will back up into the [[left atrium]] and, eventually, into the lungs. The result is a higher than normal pressure of blood within the vessels of the lung. As a result of hydrostatic forces, this high pressure leads to leaking of fluid (i.e. [[transudate]]) from the lung's blood vessels into the air-spaces ([[alveoli]]) of the lungs. The result is [[pulmonary edema]], a condition characterized by difficulty breathing, inadequate [[oxygenation]] of blood, and, if severe and untreated, death.
===Compensatory Mechanisms===
*Left ventricular systolic dysfunction is associated with a reduction in [[stroke volume]], the amount of blood the heart ejects with each heart beat.
*Left ventricular systolic dysfunction is associated with a reduction in [[stroke volume]], the amount of blood the heart ejects with each heart beat.
* The reduction in [[stroke volume]] leads to a reduction in [[cardiac output]] which is the [[stroke volume]] multiplied by the [[heart rate]].
* The reduction in [[stroke volume]] leads to a reduction in [[cardiac output]] which is the [[stroke volume]] multiplied by the [[heart rate]].
Line 27: Line 28:
*Dilation of the left ventricle increases volume and increases contractility up to a point (see [[Frank-Starling law of the heart]]).  As further LV dilation occurs, however, contractility drops, and functional [[mitral regurgitation]] ([[MR]]) may develop despite an anatomically normal [[mitral valve]].
*Dilation of the left ventricle increases volume and increases contractility up to a point (see [[Frank-Starling law of the heart]]).  As further LV dilation occurs, however, contractility drops, and functional [[mitral regurgitation]] ([[MR]]) may develop despite an anatomically normal [[mitral valve]].
* Left ventricular enlargement and lack of forward cardiac output can lead to [[left atrial enlargement]]. [[Left atrial dilation]] may lead to [[atrial fibrillation]] which occurs in 20% of patients with [[congestive heart failure]].  Atrial fibrillation diminishes left ventricular filling through the loss of the [[atrial kick]] (the atrial contraction) and due to an increase in the [[heart rate]] which reduces the time available for the left ventricle to fill.
* Left ventricular enlargement and lack of forward cardiac output can lead to [[left atrial enlargement]]. [[Left atrial dilation]] may lead to [[atrial fibrillation]] which occurs in 20% of patients with [[congestive heart failure]].  Atrial fibrillation diminishes left ventricular filling through the loss of the [[atrial kick]] (the atrial contraction) and due to an increase in the [[heart rate]] which reduces the time available for the left ventricle to fill.
===Pulmonary Edema===
* The reduction in forward cardiac output leads to a rise in the [[pulmonary capillary wedge pressure]]. [[Rales]] usually develop if the [[pulmonary capillary wedge pressure]] is >25 mm Hg. [[Rales]] may not be present in the patient with chronic heart failure. [[Rales]] may develop at even lower pressures if LV function deteriorates suddenly.
* The reduction in forward cardiac output leads to a rise in the [[pulmonary capillary wedge pressure]]. [[Rales]] usually develop if the [[pulmonary capillary wedge pressure]] is >25 mm Hg. [[Rales]] may not be present in the patient with chronic heart failure. [[Rales]] may develop at even lower pressures if LV function deteriorates suddenly.
*[[Dyspnea]] and [[orthopnea]] occur due to interstitial edema within the lungs at lower pressures.  
*[[Dyspnea]] and [[orthopnea]] occur due to interstitial edema within the lungs at lower pressures.  
*The reduction in forward cardiac output leads to [[hypoperfusion]] at rest which is suggested by [[cool extremities]], altered mentation, and declining renal function.
===End Organ Hypoperfusion===
*The reduction in forward cardiac output leads to [[hypoperfusion]] at rest which is suggested by :*[[cool extremities]]
:*[[confusion]] and altered mentation
:*Impaired renal perfusion and declining renal function


==Pathology==
==Pathology==

Revision as of 11:59, 2 April 2012

Congestive Heart Failure Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Systolic Dysfunction
Diastolic Dysfunction
HFpEF
HFrEF

Causes

Differentiating Congestive heart failure from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Clinical Assessment

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

Cardiac MRI

Echocardiography

Exercise Stress Test

Myocardial Viability Studies

Cardiac Catheterization

Other Imaging Studies

Other Diagnostic Studies

Treatment

Invasive Hemodynamic Monitoring

Medical Therapy:

Summary
Acute Pharmacotherapy
Chronic Pharmacotherapy in HFpEF
Chronic Pharmacotherapy in HFrEF
Diuretics
ACE Inhibitors
Angiotensin receptor blockers
Aldosterone Antagonists
Beta Blockers
Ca Channel Blockers
Nitrates
Hydralazine
Positive Inotropics
Anticoagulants
Angiotensin Receptor-Neprilysin Inhibitor
Antiarrhythmic Drugs
Nutritional Supplements
Hormonal Therapies
Drugs to Avoid
Drug Interactions
Treatment of underlying causes
Associated conditions

Exercise Training

Surgical Therapy:

Biventricular Pacing or Cardiac Resynchronization Therapy (CRT)
Implantation of Intracardiac Defibrillator
Ultrafiltration
Cardiac Surgery
Left Ventricular Assist Devices (LVADs)
Cardiac Transplantation

ACC/AHA Guideline Recommendations

Initial and Serial Evaluation of the HF Patient
Hospitalized Patient
Patients With a Prior MI
Sudden Cardiac Death Prevention
Surgical/Percutaneous/Transcather Interventional Treatments of HF
Patients at high risk for developing heart failure (Stage A)
Patients with cardiac structural abnormalities or remodeling who have not developed heart failure symptoms (Stage B)
Patients with current or prior symptoms of heart failure (Stage C)
Patients with refractory end-stage heart failure (Stage D)
Coordinating Care for Patients With Chronic HF
Quality Metrics/Performance Measures

Implementation of Practice Guidelines

Congestive heart failure end-of-life considerations

Specific Groups:

Special Populations
Patients who have concomitant disorders
Obstructive Sleep Apnea in the Patient with CHF
NSTEMI with Heart Failure and Cardiogenic Shock

Congestive heart failure pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Congestive heart failure pathophysiology

CDC on Congestive heart failure pathophysiology

Congestive heart failure pathophysiology in the news

Blogs on Congestive heart failure pathophysiology

Directions to Hospitals Treating Congestive heart failure pathophysiology

Risk calculators and risk factors for Congestive heart failure pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]; Saleh El Dassouki, M.D [3], Atif Mohammad, MD

Overview

Underlying Anatomic Abnormalities

Heart failure may result from an abnormality of any one of the anatomical structures of the heart:

Systolic versus Diastolic Dysfunction

Heart failure was once thought to be secondary to a depressed left ventricular ejection fraction. However, studies have shown that approximately 50% of patients who are diagnosed with heart failure have a normal ejection fraction (diastolic dysfunction). Patients may be broadly classified as having heart failure with depressed left ventricular ejection fraction (systolic dysfunction) or normal/preserved ejection fraction (diastolic dysfunction). Systolic and diastolic dysfunction commonly occur in conjunction with each other.

Pathophysiology

  • In heart failure, there is a failure of blood to move forward (forward failure) and a tendency of blood to move back ward (backward failure).
  • Normally, with respect to the left side of the heart, blood flows from the lungs, into the pulmonary veins, into the left atrium, through the mitral valve, and finally into the left ventricle. When the left ventricle cannot be normally filled during diastole, blood will back up into the left atrium and, eventually, into the lungs. The result is a higher than normal pressure of blood within the vessels of the lung. As a result of hydrostatic forces, this high pressure leads to leaking of fluid (i.e. transudate) from the lung's blood vessels into the air-spaces (alveoli) of the lungs. The result is pulmonary edema, a condition characterized by difficulty breathing, inadequate oxygenation of blood, and, if severe and untreated, death.

Compensatory Mechanisms

  • Left ventricular systolic dysfunction is associated with a reduction in stroke volume, the amount of blood the heart ejects with each heart beat.
  • The reduction in stroke volume leads to a reduction in cardiac output which is the stroke volume multiplied by the heart rate.
  • There are two compensatory mechanisms to preserve forward cardiac output (the product of stroke volume and heart rate):
  1. Dilation of the left ventricle to increase the stroke volume and
  2. Increase in heart rate

Pulmonary Edema

End Organ Hypoperfusion

  • confusion and altered mentation
  • Impaired renal perfusion and declining renal function

Pathology

Microscopic Pathology

Images courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology




References

Template:WH

Template:WS